期刊文献+

急性冠状动脉综合征患者经皮冠状动脉腔内成形术前后血清可溶性CXCL16的变化

暂未订购
导出
摘要 急性冠状动脉综合征(ACS)是危害人类健康的重要疾病.目前关于炎症与ACS再狭窄的关系认为其参与了斑块的发生发展及破裂,认识其与炎症反应的关系对冠心病的防治意义重大.
出处 《山西医药杂志(上半月)》 CAS 2012年第6期553-554,共2页 Shanxi Medical Journal
  • 相关文献

参考文献7

  • 1Hansson GK. Inflammation, atherosclerosis, and coronary ar tery disease. N Engl J Med,2005,352(16):1685-1695.
  • 2Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin 6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 2002,105 ( 16 ) : 1890 1896.
  • 3Ludwig A, Weber C. Transmembrane chemokines: versatile "special agents" in vascular inflammation. Thromb Haemost, 2007, 97(5): 694-703.
  • 4Granger CB,Goldberg RJ,Dabbous O,et al. Predictors of hos- pital mortality in the global registry of acute coronary events. Arch Intern Med,2003,163(19)~2345 2353.
  • 5Lehrke M, Millington SC, Lefterova M, et al. CXCL16 is a marker of inflammation, atheroselerosis, and acute coronary syndromes in humans. J Am Coll Cardiol, 2007, 49(4):442- 449.
  • 6Yi GW, Zeng QT. Circulating CXCL16 is related to the sever- ity of coronary artery stenosis. Arch Med Res, 2008, 39(5) 531-535.
  • 7Mitsuoka H, Toyohara M, Kume N, et al. Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syn drome comparison with high sensitivity C reactive protein. J Atheroscler Thromb, 2009, 16(5) : 586-593.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部